Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))

Clayton Harro, Xiao Sun, Jon E. Stek, Randi Y. Leavitt, Devan V. Mehrotra, Fubao Wang, Andrew J. Bett, Danilo R. Casimiro, John W. Shiver, Mark J. Dinubile, Erin Quirk

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))'. Together they form a unique fingerprint.